CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
+12.8%/yr
vs -2.8%/yr prior
5Y CAGR
+2.2%/yr
Recent acceleration
Acceleration
+15.5pp
Accelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $76.20M | -44.8% |
| 2024 | $138.10M | +36.4% |
| 2023 | $101.21M | +90.4% |
| 2022 | $53.16M | +42.5% |
| 2021 | $37.31M | -45.5% |
| 2020 | $68.43M | +19.0% |
| 2019 | $57.49M | -3.4% |
| 2018 | $59.50M | -16.9% |
| 2017 | $71.62M | +376.1% |
| 2016 | $15.04M | - |